What is reverse triiodothyronine (rT3) and what is its clinical significance?

Reverse T3 Has Minimal Clinical Utility and Should Not Be Routinely Measured

Reverse T3 (rT3) is a biologically inactive metabolite of T4 that lacks established clinical utility for diagnosis or management of thyroid disease, and routine testing is not recommended by any major endocrine society guidelines.

What is Reverse T3?

Reverse T3 (3',5'-triiodothyronine) is produced through inner ring deiodination of T4 by type 1 and type 3 deiodinase enzymes 1. Unlike active T3, rT3 binds weakly to thyroid hormone receptors and is traditionally considered an inactive end-product that diverts T4 away from active T3 production 1.

Clinical Significance: Limited and Context-Dependent

When rT3 Levels Change

Nonthyroidal Illness (Euthyroid Sick Syndrome):

• rT3 increases during severe acute illness, starvation, or major medical conditions 2, 3
• This occurs alongside low T3 and normal or low T4 levels with normal/low TSH 3
• Critical point: These changes represent an adaptive physiological response, not true thyroid dysfunction requiring treatment 3

Aging:

• Reduced deiodinase type 1 activity with aging leads to rT3 elevation 2
• This is a normal physiological change without pathological significance 2

Medications:

• Amiodarone inhibits rT3 metabolism, causing elevated levels 1
• Glucocorticoids and dopamine also affect thyroid hormone economy 3

Why rT3 Testing Is Not Recommended

Lack of Guideline Support: The French Endocrine Society (2020) explicitly states that rT3 concentration "depends on confounding factors such as general, severe or consumptive disease" 2. Importantly, thyroid assessment should not be performed during acute illness episodes unless diagnosis would alter ongoing treatment 2. No major guidelines from AACE/ATA 3 or other societies recommend routine rT3 measurement.

Practice Variation Analysis: A national reference laboratory study revealed concerning patterns 4:

• Only 20% of providers ordering thyroid tests ever order rT3
• Just 0.1% of providers (100 out of 60,733) accounted for 29.5% of all rT3 orders
• 60 of these high-volume orderers were functional medicine practitioners
• 95% of providers who ordered rT3 placed ≤2 orders total

Inappropriate Utilization: An institutional review found 55% (11/20) of rT3 orders appeared inappropriate for clinical context, and these inappropriate orders were less likely to have endocrinologist involvement 5.

Common Pitfalls and Misconceptions

The "rT3 Dominance" Myth

Functional medicine practitioners often claim:

• High rT3 blocks T3 from binding to receptors
• rT3 testing guides T3-only replacement therapy
• Elevated rT3 explains persistent symptoms despite normal TSH

The evidence shows:

• Patients with normal thyroid tests but hypothyroid symptoms do not benefit from L-thyroxine treatment 3
• Treatment of such patients carries substantial risk (20% develop subclinical or overt hyperthyroidism) 3
• No peer-reviewed evidence supports using rT3 to direct T3-only therapy 4

When NOT to Order Thyroid Tests (Including rT3)

Avoid thyroid assessment during:

• Acute intercurrent illness without strong suspicion of thyroid dysfunction 2
• Unscheduled hospital stays 2
• Severe or consumptive disease states 2

Rationale: Thyroid function tests are nonspecifically disturbed in acute illness, leading to unnecessary treatment and costly follow-up 2. Wait 4-12 months after acute episode resolution before reassessing 2.

Appropriate Thyroid Function Testing

Standard approach for suspected thyroid dysfunction:

1. TSH is the primary screening test 3
2. If TSH is abnormal, measure free T4 3
3. Total or free T3 may be added if hyperthyroidism suspected with normal T4 6
4. rT3 adds no diagnostic value to this algorithm

For monitoring hypothyroidism treatment:

• TSH is the most reliable therapeutic endpoint 3
• Target TSH within normal reference range (0.4-4.12 mIU/L) 3
• Free T4 and T3 levels lack sufficient specificity as therapeutic endpoints alone 3

Rare Exceptions Where rT3 Might Be Considered

While not recommended for routine use, rT3 measurement may provide diagnostic information in:

• Genetic conditions affecting iodothyronine deiodinases 1
• Thyroid transporter or transport protein disorders 1
• Research settings investigating thyroid hormone metabolism

However, these situations require endocrinology consultation 3, 5, not routine ordering by primary care or functional medicine practitioners.

Bottom Line Recommendation

Do not order rT3 testing. If thyroid dysfunction is suspected:

• Order TSH first
• Add free T4 if TSH is abnormal
• Consult endocrinology for complex cases or discrepant results 5
• Avoid testing during acute illness 2
• Recognize that persistent symptoms with normal thyroid tests do not warrant thyroid hormone treatment 3

The widespread ordering of rT3 by a small subset of practitioners represents low-value care without evidence-based support 4, 5. Trust evidence-based endocrinology guidelines over unsubstantiated functional medicine claims 5.